[HTML][HTML] Understanding and managing large B cell lymphoma relapses after chimeric antigen receptor T cell therapy
M Byrne, OO Oluwole, B Savani, NS Majhail… - Biology of Blood and …, 2019 - Elsevier
Most patients with large cell lymphoma are cured with frontline chemoimmunotherapy. For
individuals with refractory disease and those who relapse after conventional therapies …
individuals with refractory disease and those who relapse after conventional therapies …
Understanding and Managing Large B Cell Lymphoma Relapses after Chimeric Antigen Receptor T Cell Therapy
M Byrne, OO Oluwole, B Savani… - Biology of blood …, 2019 - pubmed.ncbi.nlm.nih.gov
Most patients with large cell lymphoma are cured with frontline chemoimmunotherapy. For
individuals with refractory disease and those who relapse after conventional therapies …
individuals with refractory disease and those who relapse after conventional therapies …
[HTML][HTML] Understanding and Managing Large B Cell Lymphoma Relapses after Chimeric Antigen Receptor T Cell Therapy
M Byrne, OO Oluwole, B Savani… - Biology of blood and …, 2019 - ncbi.nlm.nih.gov
Most patients with large cell lymphoma are cured with frontline chemoimmunotherapy. For
individuals with refractory disease and those who relapse after conventional therapies …
individuals with refractory disease and those who relapse after conventional therapies …
[HTML][HTML] Understanding and Managing Large B Cell Lymphoma Relapses after Chimeric Antigen Receptor T Cell Therapy
M Byrne, OO Oluwole, B Savani, NS Majhail… - Biology of Blood and …, 2019 - tctjournal.org
Most patients with large cell lymphoma are cured with frontline chemoimmunotherapy. For
individuals with refractory disease and those who relapse after conventional therapies …
individuals with refractory disease and those who relapse after conventional therapies …
Understanding and Managing Large B Cell Lymphoma Relapses after Chimeric Antigen Receptor T Cell Therapy.
M Byrne, OO Oluwole, B Savani, NS Majhail… - Biology of Blood and …, 2019 - europepmc.org
Most patients with large cell lymphoma are cured with frontline chemoimmunotherapy. For
individuals with refractory disease and those who relapse after conventional therapies …
individuals with refractory disease and those who relapse after conventional therapies …
[HTML][HTML] Understanding and Managing Large B Cell Lymphoma Relapses after Chimeric Antigen Receptor T Cell Therapy
M Byrne, OO Oluwole, B Savani, NS Majhail… - Biology of Blood and …, 2019 - astctjournal.org
Most patients with large cell lymphoma are cured with frontline chemoimmunotherapy. For
individuals with refractory disease and those who relapse after conventional therapies …
individuals with refractory disease and those who relapse after conventional therapies …